pharma

By Jonah Comstock June 23, 2016
Larry Brooks, director of business innovation at Boehringer Ingelheim, took the stage in a fireside chat with Medullan EVP and Managing Director Jonathan Chen at MobiHealthNews 2016 in San Francisco last week. Brooks has been leading Boehringer's digital health group for the past five years, and he shed some light on how the pharma company's approach to the space has changed during that time. "...
By Jonah Comstock June 16, 2016
Global pharmaceutical company AstraZeneca has launched a new patient-facing mobile app that includes a virtual savings card, a prescription tracker, and educational materials. The app, available in the US on the iOS App Store and Google Play store, is called AZhelps. “AstraZeneca is committed to providing affordable medicines and programs that help patients get the support they need," Lori...
By Jonah Comstock January 21, 2016
According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology. Financial Times added in its report that the JV could be worth up to $1 billion. Very little information about the prospective partnership is available, but it makes sense for both companies: Qualcomm has already teamed up with both Roche and Novartis on major...
By Jonah Comstock December 16, 2015
One of the biggest ways the changing digital health landscape will affect the pharma industry is that pharma companies increasingly stand to lose control over their own stories, according to a new report from McKinsey & Company, who spoke to 20 thought leaders in various pharma-adjacent sectors. "As the lines among payors, providers, and pharma companies blur, carefully controlled trial data...
By Jonah Comstock August 20, 2015
Bryan Roberts Bryan Roberts, one of Venrock's healthcare-focused investment partners, has some rules of thumb for investing in digital health -- and for what to pass up. Roberts' portfolio included six successful exits last year, the Wall Street Journal reports, and this year he has invested in Stride Health, Lyra Health, Intarcia Therapeutics, and Grand Rounds. In a recent interview with the...
By Jonah Comstock August 3, 2015
Sixty-six percent of all pharma app downloads in the United States, the United Kingdom, and Germany, were downloads of the top 10 apps according to an infographic recently released by German app company SmartPatient (not to be confused with Roni Zeiger-founded online patient community SmartPatients). The Munich-based company analyzed 359 apps from 20 pharma companies: Abbott Laboratories, Amgen,...
By Jonah Comstock July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular. Last week the...
By Aditi Pai March 16, 2015
More collaboration between chief information officers (CIO) and chief marketing officers (CMO) at pharmaceutical companies could lead to more optimized use of digital technology, according to a survey from Accenture. Accenture interviewed 22 CIOs and 24 CMOs from pharmaceutical companies in eight countries that were bringing in at least $5 billion in annual revenues. While 91 percent of CIOs at...
By Jonah Comstock March 4, 2015
At Everyday Health's fourth quarterly earnings call since going public last year, CEO Ben Wolin spoke about the growing importance of mobile to the company's business, as well as some of the other trends that are driving the company. Everyday Health offers consumers an app and web tool to aggregate health information on a variety of topics, including nutrition, diabetes, fitness, digestive health...
By Jonah Comstock February 25, 2015
Paul Ivans As payors and providers advance toward outcomes-based medicine, that shift is affecting pharmaceutical companies as well. As decisions about prescribing shift away from the doctor, who has been the primary recipient of pharma marketing for the past 20 years, to the C-level of integrated delivery networks (IDNs) and accountable care organizations (ACOs), pharma is going to have to...

Editor's Pick